ArticleMarine drugs2026

Discovery of RUVBL1 as a Target of the Marine Alkaloid Caulerpin via MS-Based Functional Proteomics.

Alessandra Capuano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.